No part of this description should be interpreted as suggesting human use, animal use, cosmetic outcomes, skin-related outcomes, anti-aging outcomes, treatment outcomes, prevention outcomes, recovery, diagnosis, cure, or personal application
Polycystic Ovary Syndrome (PCOS) - 5-10% of women 50% lower glutathione levels compared to women without PCOS 3-4x higher risk of preeclampsia 3x higher risk of gestational diabetes Critical concern: With 50% lower baseline glutathione, the "safe" dose is effectively cut in half IVF Conception - 2-5% of births (up to 6-8% in some countries) Women who conceive via IVF experience dramatic antioxidant depletion: 70% reduction in plasma antioxidant capacity 83% reduction in follicular fluid antioxidant capacity 50-100%+ increase in oxidative stress markers With over 5 million babies born via IVF globally, this represents a large high-risk population Gallbladder Dysfunction - 10% of pregnant women Up to 10% develop gallstones or biliary sludge Intrahepatic cholestasis: 0.4-10% of pregnancies CRITICAL: Fatal Outcomes Documented at Therapeutic Doses The first case of a pregnant woman with intrahepatic cholestasis who died from liver failure after taking THERAPEUTIC/NORMAL doses of acetaminophen was reported in 2022
y l thnh phn thit yu trong vic chng lo ha t bn trong
Most clinical evidence supports liposomal or acetyl-glutathione formulations taken on an empty stomach 3060 minutes before meals for better cellular uptake and reduced breakdown
Aspirin-induced alterations in GSH metabolism GSH-Px activity in HepG2 cells was significantly increased after ASA treatment (Figure 5A and B).The enzyme activity was further increased (40%) in GSH-depleted- 5 mol/ml ASA treated cells and almost 2-fold in GSH-depleted 10 mol/ml ASA treated cells in the PMS while mitochondria showed only 1530% increased activity in GSH-depleted cells
There are so many supplements out there that can be beneficial for your liver, from milk thistle to certain probiotics to NAC
